PharmaBoardroom

Spain’s Clinical Trial Landscape

Within the past decade, Spain has developed into a top player in the European clinical trial network. The pharmaceutical industry has been increasing…

Rana Azfar – Vice-President & General Manager, Novo…

Rana Azfar, vice-president & general manager of Novo Nordisk Korea offers his impressions of the Korean market since moving from Pakistan. Azfar…

Juan Abarca Cidón – President, HM Hospitales, Spain

Dr Juan Abarca Cidón, president of HM Hospitales, one of Spain’s leading private health groups, gives insight into the private health sector of the…

Young-Woo Park – CEO, Y-Biologics, South Korea

Young-Woo Park, CEO of Y-Biologics - renowned for their library with diversity of 1011 - unveils their plan to be the first in Korea to develop the…

Damaso Molero – General Manager, 3P Biopharmaceuticals,…

Damaso Molero, general manager of 3P Biopharmaceuticals, a leading Spanish CDMO, highlights the growth of the company and the need to continuously…

Yong Zu Kim – Founder and CEO, Lego Chem, South Korea

Yong Zu Kim, founder and CEO of Lego Chem, discusses his company’s two areas of focus, anti-infectives and antibody drug conjugates. Dr Kim explains…

Antonio Alarco – Senator Elect of Tenerife; Former Health…

Dr Antonio Alarco gives his insider take on the future of Spanish healthcare, personalized medicine, and the areas in which Spain needs to improve.…

Kyoung-June Lee – CEO, JW CreaGene, South Korea

Kyoung-June Lee, CEO of JW CreaGene, lifts the lid on their novel technology of developing an immuno-oncology treatment from dendritic cells, which…

BG Rhee – CEO, SCM Lifescience, South Korea

Dr BG Rhee, CEO of SCM Lifescience discusses their patented proprietary subfraction technology to extract high purity cell cultures, and the impact…

Alfonso Beltrán García-Echániz – Director, FIPSE, Spain

Alfonso Beltrán García-Echániz, director of the Spanish Foundation for Innovation and Prospective Health (FIPSE), highlights the foundation’s…

Thierry Hulot – President Biopharma, Merck France

Thierry Hulot, president biopharma of Merck France, explains how France has become more open to diversity, while still needing significant reforms in…

Jong In Lim – President, Institute of Cyber Security and…

Professor Jong In Lim, cyber security specialist and president of the Institute for Cyber Security and Privacy (ICSP) provides his assessment of the…

Tagged with R